234 related articles for article (PubMed ID: 30664213)
1. Piperazine ferulate ameliorates the development of diabetic nephropathy by regulating endothelial nitric oxide synthase.
Yang YY; Shi LX; Li JH; Yao LY; Xiang DX
Mol Med Rep; 2019 Mar; 19(3):2245-2253. PubMed ID: 30664213
[TBL] [Abstract][Full Text] [Related]
2. Astragaloside IV protects against diabetic nephropathy via activating eNOS in streptozotocin diabetes-induced rats.
Fan Y; Fan H; Zhu B; Zhou Y; Liu Q; Li P
BMC Complement Altern Med; 2019 Dec; 19(1):355. PubMed ID: 31805910
[TBL] [Abstract][Full Text] [Related]
3. Imbalance of glomerular VEGF-NO axis in diabetic rats: prevention by chronic therapy with propyl gallate.
Tian S; Gan Y; Li J; Wang L; Shen J; Liu T; Ye T; Liu H; Liu D; Deng Y; Wang W
J Nephrol; 2011; 24(4):499-506. PubMed ID: 21425119
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiles of glomerular endothelial cells support their role in the glomerulopathy of diabetic mice.
Fu J; Wei C; Zhang W; Schlondorff D; Wu J; Cai M; He W; Baron MH; Chuang PY; Liu Z; He JC; Lee K
Kidney Int; 2018 Aug; 94(2):326-345. PubMed ID: 29861058
[TBL] [Abstract][Full Text] [Related]
5. Puerarin attenuates diabetic kidney injury through the suppression of NOX4 expression in podocytes.
Li X; Cai W; Lee K; Liu B; Deng Y; Chen Y; Zhang X; He JC; Zhong Y
Sci Rep; 2017 Nov; 7(1):14603. PubMed ID: 29097815
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II type 1 receptor blocker ameliorates uncoupled endothelial nitric oxide synthase in rats with experimental diabetic nephropathy.
Satoh M; Fujimoto S; Arakawa S; Yada T; Namikoshi T; Haruna Y; Horike H; Sasaki T; Kashihara N
Nephrol Dial Transplant; 2008 Dec; 23(12):3806-13. PubMed ID: 18596126
[TBL] [Abstract][Full Text] [Related]
7. NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy.
Satoh M; Fujimoto S; Haruna Y; Arakawa S; Horike H; Komai N; Sasaki T; Tsujioka K; Makino H; Kashihara N
Am J Physiol Renal Physiol; 2005 Jun; 288(6):F1144-52. PubMed ID: 15687247
[TBL] [Abstract][Full Text] [Related]
8. Liraglutide ameliorates renal injury in streptozotocin‑induced diabetic rats by activating endothelial nitric oxide synthase activity via the downregulation of the nuclear factor‑κB pathway.
Zhou SJ; Bai L; Lv L; Chen R; Li CJ; Liu XY; Yu DM; Yu P
Mol Med Rep; 2014 Nov; 10(5):2587-94. PubMed ID: 25215431
[TBL] [Abstract][Full Text] [Related]
9. The role of adrenomedullin and receptors in glomerular hyperfiltration in streptozotocin-induced diabetic rats.
Hiragushi K; Wada J; Eguchi J; Matsuoka T; Yasuhara A; Hashimoto I; Yamashita T; Hida K; Nakamura Y; Shikata K; Minamino N; Kangawa K; Makino H
Kidney Int; 2004 Feb; 65(2):540-50. PubMed ID: 14717924
[TBL] [Abstract][Full Text] [Related]
10. Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice.
Kanetsuna Y; Takahashi K; Nagata M; Gannon MA; Breyer MD; Harris RC; Takahashi T
Am J Pathol; 2007 May; 170(5):1473-84. PubMed ID: 17456755
[TBL] [Abstract][Full Text] [Related]
11. Arginase inhibition mediates renal tissue protection in diabetic nephropathy by a nitric oxide synthase 3-dependent mechanism.
You H; Gao T; Cooper TK; Morris SM; Awad AS
Kidney Int; 2013 Dec; 84(6):1189-97. PubMed ID: 23760286
[TBL] [Abstract][Full Text] [Related]
12. Propyl gallate plays a nephroprotective role in early stage of diabetic nephropathy associated with suppression of glomerular endothelial cell proliferation and angiogenesis.
Tian S; Tang J; Liu H; Wang L; Shen J; Li J; Gan Y
Exp Diabetes Res; 2012; 2012():209567. PubMed ID: 22988451
[TBL] [Abstract][Full Text] [Related]
13. Long-term administration of the histone deacetylase inhibitor vorinostat attenuates renal injury in experimental diabetes through an endothelial nitric oxide synthase-dependent mechanism.
Advani A; Huang Q; Thai K; Advani SL; White KE; Kelly DJ; Yuen DA; Connelly KA; Marsden PA; Gilbert RE
Am J Pathol; 2011 May; 178(5):2205-14. PubMed ID: 21514434
[TBL] [Abstract][Full Text] [Related]
14. Piperazine ferulate attenuates high glucose‑induced mesangial cell injury via the regulation of p66
Yang YY; Deng RR; Chen Z; Yao LY; Yang XD; Xiang DX
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760157
[TBL] [Abstract][Full Text] [Related]
15. Low nitric oxide bioavailability upregulates renal heparin binding EGF-like growth factor expression.
Miyazawa T; Zeng F; Wang S; Fan X; Cheng H; Yang H; Bian A; Fogo AB; Harris RC
Kidney Int; 2013 Dec; 84(6):1176-88. PubMed ID: 23760291
[TBL] [Abstract][Full Text] [Related]
16. eNOS deficiency predisposes podocytes to injury in diabetes.
Yuen DA; Stead BE; Zhang Y; White KE; Kabir MG; Thai K; Advani SL; Connelly KA; Takano T; Zhu L; Cox AJ; Kelly DJ; Gibson IW; Takahashi T; Harris RC; Advani A
J Am Soc Nephrol; 2012 Nov; 23(11):1810-23. PubMed ID: 22997257
[TBL] [Abstract][Full Text] [Related]
17. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes.
Fang L; Radovits T; Szabó G; Mózes MM; Rosivall L; Kökény G
Nephrol Dial Transplant; 2013 Jul; 28(7):1751-61. PubMed ID: 23203993
[TBL] [Abstract][Full Text] [Related]
18. Nephrin loss is reduced by grape seed proanthocyanidins in the experimental diabetic nephropathy rat model.
Li X; Gao Z; Gao H; Li B; Peng T; Jiang B; Yang X; Hu Z
Mol Med Rep; 2017 Dec; 16(6):9393-9400. PubMed ID: 29152654
[TBL] [Abstract][Full Text] [Related]
19. Combination of telmisartan with sildenafil ameliorate progression of diabetic nephropathy in streptozotocin-induced diabetic model.
El-Mahdy NA; El-Sayad ME; El-Kadem AH
Biomed Pharmacother; 2016 Jul; 81():136-144. PubMed ID: 27261587
[TBL] [Abstract][Full Text] [Related]
20. Diosmetin Attenuates Akt Signaling Pathway by Modulating Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells (NF-κB)/Inducible Nitric Oxide Synthase (iNOS) in Streptozotocin (STZ)-Induced Diabetic Nephropathy Mice.
Jiang Y; Liu J; Zhou Z; Liu K; Liu C
Med Sci Monit; 2018 Oct; 24():7007-7014. PubMed ID: 30278036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]